enzastaurin has been researched along with amphetamine in 1 studies
Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (amphetamine) | Trials (amphetamine) | Recent Studies (post-2010) (amphetamine) |
---|---|---|---|---|---|
188 | 52 | 99 | 13,071 | 329 | 1,977 |
Protein | Taxonomy | enzastaurin (IC50) | amphetamine (IC50) |
---|---|---|---|
Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | 0.96 | |
Cytochrome P450 2A6 | Homo sapiens (human) | 3.5 | |
Cytochrome P450 2A5 | Mus musculus (house mouse) | 2.85 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.96 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.96 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altshuler, RD; Carpenter, CA; Franke, TJ; Gnegy, ME; Jutkiewicz, EM | 1 |
1 other study(ies) available for enzastaurin and amphetamine
Article | Year |
---|---|
The protein kinase Cβ-selective inhibitor, enzastaurin, attenuates amphetamine-stimulated locomotor activity and self-administration behaviors in rats.
Topics: Amphetamine; Animals; Behavior, Addictive; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Indoles; Locomotion; Male; Protein Kinase C beta; Rats; Rats, Sprague-Dawley; Self Administration | 2019 |